<p>B6 mice were primed, or primed and boosted with Lv-OVA, and then were adoptively transferred i.v. with 2×10<sup>6</sup> CFSE-labeled OT-I (<b>A</b>) or OT-II (<b>B</b>) splenocytes at the indicated days. Three days later the LNs were harvested and the CFSE dilution was assessed by flow cytometry to analyze the proliferation of the transferred CD8<sup>+</sup> or CD4<sup>+</sup> T cells, respectively. Results are shown as representative flow plots gating on dividing CD8<sup>+</sup> or CD4<sup>+</sup> lymphocytes; numbers indicate the percentages of dividing cells and represent the mean of three mice per group for each time point ± SE. One representative out of 2 independent experiments is depicted. *, <i>P</i><0.01, primed mice versus boos...
<p>CD4+ T cells, isolated from OT-II mice, were labeled with CFSE and adoptively transferred into re...
<p>(A, B) WT or TLR4<sup>−/−</sup> recipient mice were injected i.v. with CFSE labeled OT-I T cells....
<p>Equal numbers of CFSE-labeled P14 cells (TcR-transgenic CD8<sup>+</sup> T cells specific for LCMV...
<p>(<b>A</b>) B6 mice were primed, or primed and boosted intradermally with 5×10<sup>6</sup> TU of L...
<p>10<sup>4</sup> P14 cells and 10<sup>4</sup> SMARTA transgenic T cells from uninfected mice were c...
<p>Purified CD4 T cells derived from spleens of LCMV- and <i>actA<sup>−</sup></i>LmOva-immune B6 don...
<p>(A) C57BL/6 mice were injected with CD45.1<sup>+</sup> WT DC or CD45.1<sup>+</sup> WT DC loaded w...
<p>2×10<sup>6</sup> CFSE-labelled purified CD4<sup>+</sup> and CD8<sup>+</sup> T cells specific for ...
<p>Naive SMARTA cells were CFSE-labeled and transferred either to mice that had been infected with L...
<p>Mice were primed with DNA and boosted with Ad5-NS3/4A (Ad5) (10<sup>9</sup> vp), VV-NS3/4A (VV) (...
<p>Cells were harvested from the spleens of Hu-PBMC NSG and BRG mice at weekly intervals following t...
<p>Thy1.2 C57BL/6 mice that healed their primary low dose (1×10<sup>3</sup>) or high dose (2×10<sup>...
<p>Mice containing approximately 1.4×10<sup>5</sup> CFSE-labeled SMARTA CD4<sup>+</sup> T cells were...
<p>OT-II T-cells were purified from the lymph nodes and spleen of OT-II mice and labeled with CFSE. ...
<p>Mice were injected with 1×10<sup>6</sup> tumor cells/mouse one week prior to Cy and vaccine treat...
<p>CD4+ T cells, isolated from OT-II mice, were labeled with CFSE and adoptively transferred into re...
<p>(A, B) WT or TLR4<sup>−/−</sup> recipient mice were injected i.v. with CFSE labeled OT-I T cells....
<p>Equal numbers of CFSE-labeled P14 cells (TcR-transgenic CD8<sup>+</sup> T cells specific for LCMV...
<p>(<b>A</b>) B6 mice were primed, or primed and boosted intradermally with 5×10<sup>6</sup> TU of L...
<p>10<sup>4</sup> P14 cells and 10<sup>4</sup> SMARTA transgenic T cells from uninfected mice were c...
<p>Purified CD4 T cells derived from spleens of LCMV- and <i>actA<sup>−</sup></i>LmOva-immune B6 don...
<p>(A) C57BL/6 mice were injected with CD45.1<sup>+</sup> WT DC or CD45.1<sup>+</sup> WT DC loaded w...
<p>2×10<sup>6</sup> CFSE-labelled purified CD4<sup>+</sup> and CD8<sup>+</sup> T cells specific for ...
<p>Naive SMARTA cells were CFSE-labeled and transferred either to mice that had been infected with L...
<p>Mice were primed with DNA and boosted with Ad5-NS3/4A (Ad5) (10<sup>9</sup> vp), VV-NS3/4A (VV) (...
<p>Cells were harvested from the spleens of Hu-PBMC NSG and BRG mice at weekly intervals following t...
<p>Thy1.2 C57BL/6 mice that healed their primary low dose (1×10<sup>3</sup>) or high dose (2×10<sup>...
<p>Mice containing approximately 1.4×10<sup>5</sup> CFSE-labeled SMARTA CD4<sup>+</sup> T cells were...
<p>OT-II T-cells were purified from the lymph nodes and spleen of OT-II mice and labeled with CFSE. ...
<p>Mice were injected with 1×10<sup>6</sup> tumor cells/mouse one week prior to Cy and vaccine treat...
<p>CD4+ T cells, isolated from OT-II mice, were labeled with CFSE and adoptively transferred into re...
<p>(A, B) WT or TLR4<sup>−/−</sup> recipient mice were injected i.v. with CFSE labeled OT-I T cells....
<p>Equal numbers of CFSE-labeled P14 cells (TcR-transgenic CD8<sup>+</sup> T cells specific for LCMV...